자료유형  

 학위논문

Control Number  

0016934222

International Standard Book Number  

9798380125468

Dewey Decimal Classification Number  

614

Main Entry-Personal Name  

Ann Hillman, Lisa.

Publication, Distribution, etc. (Imprint  

[S.l.] : University of Minnesota., 2023

Publication, Distribution, etc. (Imprint  

Ann Arbor : ProQuest Dissertations & Theses, 2023

Physical Description  

1 online resource(258 p.)

General Note  

Source: Dissertations Abstracts International, Volume: 85-02, Section: B.

General Note  

Advisor: Schommer, Jon C.;Ramalho de Oliveira, Djenane.

Dissertation Note  

Thesis (Ph.D.)--University of Minnesota, 2023.

Restrictions on Access Note  

This item must not be sold to any third party vendors.

Summary, Etc.  

요약Chronic kidney disease affects 37 million Americans (14.0%), results in poor quality of life and mortality, is costly for the US Healthcare system and disproportionately impacts Black Americans. The optimal time to intervene in the course of chronic kidney disease is early, making treatment of the disease and risk factors, often with medications, a priority. The African-American woman's lived experience lies at the intersection of race, gender, and other relevant social factors impacting medication use. Knowledge of the experience of medication taking of these women in the context of their everyday lives may shed meaningful insight into person-centered interventions aimed to improve patients' use and experience with medications. Objectives are (1) Explore the medication experiences of African-American women taking medications for chronic diseases related to chronic kidney disease, and (2) Reveal individuals' prioritization of medication-related decisions in the context of their everyday lives. A phenomenological approach was undertaken. One-on-one interviews were conducted with seventeen African-American adult women taking at least one medication for chronic kidney disease or a chronic disease that places them at high risk (hypertension or diabetes mellitus) for chronic kidney disease. The existential structures of the lifeworld as described by French Philosopher Merleau-Ponty were used to guide thematic analysis of data and was based in traditions of phenomenology. Five themes of (1) guided by a personal agency with medications, (2) sense of personal duty to care for self and others, (3) making sense of the body and self with medications, (4) staying on track with medications and with life, and (5) desire to living freely with medications and from their constraints are described. Priorities with medication taking behaviors in daily living experience were revealed to be: (1) safety and security, (2) singularity of experience, and (3) autonomy and vitality. Patient-centered care needs to consider the patient and their medication taking from the perspective of their priorities and daily living. Health care professionals need to practice self-awareness and listen attentively to understand the experiences their patients have with their medications. Knowledge of the medication experience can then inform strategies and interventions that are meaningful to patients. 

Subject Added Entry-Topical Term  

Pharmaceutical sciences.

Subject Added Entry-Topical Term  

Health sciences.

Subject Added Entry-Topical Term  

Social research.

Index Term-Uncontrolled  

African-American women

Index Term-Uncontrolled  

Kidney disease

Index Term-Uncontrolled  

Lived experience

Index Term-Uncontrolled  

Medication experience

Index Term-Uncontrolled  

Pharmacist

Index Term-Uncontrolled  

Phenomenology

Added Entry-Corporate Name  

University of Minnesota Social and Administrative Pharmacy

Host Item Entry  

Dissertations Abstracts International. 85-02B.

Host Item Entry  

Dissertation Abstract International

Electronic Location and Access  

로그인을 한후 보실 수 있는 자료입니다.

Control Number  

joongbu:641553